ALDR Shares Outstanding History
Below is a table of the ALDR shares outstanding history going back to 5/8/2014:

Date ALDR Shares Outstanding

Also see: ALDR Market Cap History
ALDR Historical Shares Outstanding:
+12.81% CAGR
ALDR Historical Shares Outstanding: +12.81% CAGR

Mouse over chart for data details
5/8/2014 ...12/31/2018
Alder Biopharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to transform the treatment paradigm in migraine. Co. is focusing on eptinezumab (ALD403). Eptinezumab is a humanized immunoglobulin G1 monoclonal antibody for calcitonin gene-related peptide ligand, a small protein and a target to drive migraine initiation, maintenance and chronification. Co.'s product candidate pipeline also includes ALD1910, a neutralizing monoclonal antibody with reactivity to that targets pituitary adenylate cyclase-activating polypeptide-38. We show 24 historical shares outstanding datapoints in our coverage of ALDR's shares outstanding history.

Understanding the changing numbers of ALDR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ALDR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ALDR by allowing them to research ALDR shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ALDR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Alder Biopharmaceuticals (ALDR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ALDX Shares Outstanding History
ALEC Shares Outstanding History
ALGN Shares Outstanding History
ALGS Shares Outstanding History
ALHC Shares Outstanding History
ALIM Shares Outstanding History
ALKS Shares Outstanding History
ALLK Shares Outstanding History
ALLO Shares Outstanding History
ALNA Shares Outstanding History
More Healthcare companies »


ALDR Shares Outstanding History | | Copyright © 2017 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.